Riboflavin status in acute ischaemic stroke

European Journal of Clinical Nutrition

Volumn 61, Issue 10, 2007, Pages 1237-1240

  Gariballa, S ^a,b   Ullegaddi, R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE REDUCTASE; RIBOFLAVIN; VITAMIN B GROUP;

AGED; ARTICLE; ASSAY; BRAIN EDEMA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; RANDOMIZATION; RIBOFLAVIN DEFICIENCY; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; VENOUS BLOOD; VITAMIN SUPPLEMENTATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DIETARY SUPPLEMENTS; ERYTHROCYTES; FEMALE; GLUTATHIONE REDUCTASE; HUMANS; MALE; NUTRITIONAL STATUS; OXIDATIVE STRESS; PREVALENCE; RIBOFLAVIN; RIBOFLAVIN DEFICIENCY; STROKE; VITAMIN B COMPLEX;

EID: 34948848079     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602666     Document Type: Article

References (11)

1. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991). Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337, 1521-1526.
2. Betz AL, Ren XD, Ennis SR, Hultquist DE (1994). Riboflavin reduces edema in focal cerebral ischemia. Acta Neurochir Suppl (Wien) 60, 314-317.
3. Finch SDW, Lowe C, Bates CJ, Prentice A, Smithers G, Clarke PC (1998). National Diet and Nutrition Survey of People Aged 65 Years and Older vol. 1. The Stationary Office: London.
4. Hankey GJ, Eikelboom JW (1999). Homocysteine, vascular disease. Lancet 354, 407-413.
5. Hoane MR, Wolyniak JG, Akstulewicz SL (2005). Administration of riboflavin improves behavioural outcome and reduces oedema formation and glial fibrillary acidic protein expression after traumatic brain injury. J Neurotrauma 22, 1112.
6. Homocysteine Studies Collaboration (2002). Homocysteine, risk of ischaemic heart disease, stroke: A meta-analysis. JAMA 288, 2015-2022.
7. Hultquist DE, Xu F, Quandt KS, Shlafer M, Mack CP, Till GO et al. (1993). Evidence that NADPH-dependent methaemoglobin reductase, administered riboflavin protect tissues from oxidative injury. Am J Haematol 42, 13-18.
8. Mack CP, Hultquist DE, Shlafer M (1995). Myocardial flavin reductase and riboflavin: A potential role in decreasing reoxygenation injury. Biochem Biophys Res Commun 212, 35-40.
9. McNulty H, Dowey LC, Strain JJ, Dunne A, Ward M, Molloy AM et al. (2006). Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677 TT. Circulation 113, 74-80.
10. Powers HJ, Bates CJ, Duerden JM (1983). Effects of riboflavin deficiency in rats on some aspects of iron metabolism. Int J Vitam Nutr Res 53, 371-376.
11. Ullegaddi R, Powers HJ, Gariballa SE (2006). Antioxidant supplementation with or without B-group vitamins after acute isthaemic stroke. JPEN 30, 108-114.